Latest News about NVO
Recent news which mentions NVO
The weight-loss drugs are coming for these companies — but here’s why Coke, others, may be spared, says JPMorgan
October 24, 2023
From MarketWatch
From Motley Fool
3 Top Consumer Staples Stocks to Buy In Q4
October 23, 2023
From InvestorPlace
3 Stocks to Buy From the ‘Buy the Dip’ ETF
October 23, 2023
From InvestorPlace
3 Healthcare Stocks to Invest in for a Big Shot of Gains
October 23, 2023
From InvestorPlace
2 Stock-Split Stocks That Could Plunge Up to 89%, According to Select Wall Street Analysts
October 23, 2023
From Motley Fool
3 Unstoppable Stocks to Buy Sooner Rather Than Later
October 22, 2023
From Motley Fool
Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits
October 21, 2023
From Benzinga
This Stock-Split Stock Is Beating Both Apple and Microsoft in 2023 -- With No Artificial Intelligence (AI) Tailwind at All
October 21, 2023
From Motley Fool
3 Mutual Funds to Invest in for Pro Management and Low Fees
October 20, 2023
From InvestorPlace
1 Market-Beating Stock to Buy Near Its 52-Week High
October 19, 2023
From Motley Fool
4 Ways to Grow $100,000 Into $1 Million for Retirement
October 19, 2023
From Motley Fool
1 Thing You'd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro
October 19, 2023
From Motley Fool
Beware Of Fake Novo Nordisk's Ozempic - European, UK Regulators Warn About Fake Prefilled Pens
October 19, 2023
Tickers
NVO
From Benzinga
From MarketWatch
7 Stocks to Buy and Hold for a Lifetime of Wealth
October 19, 2023
From InvestorPlace
Nestle works on new range of weight-loss drug companion products as sales miss estimates
October 19, 2023
Tickers
NVO
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
From Benzinga
Abbott Labs’ stock rises as third-quarter results beat estimates despite plunging COVID sales
October 18, 2023
From MarketWatch
3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and Pundits
October 18, 2023
From Motley Fool
Here’s what Ozempic, ASML and India’s fintech industry all have in common — and how one ETF takes advantage of all three
October 17, 2023
From MarketWatch
Ozempic Sales Are Skyrocketing Faster Than Expected. Here's Why That's Great News for Eli Lilly Stock.
October 17, 2023
From Motley Fool
Food and Beverage Stocks Look Appetizing After Ozempic Selloff
October 16, 2023
From InvestorPlace
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
From Benzinga
From Benzinga
1 Big Risk Facing Ozempic, Wegovy, and Other GLP-1 Weight-Loss Drugs
October 14, 2023
Tickers
NVO
From Motley Fool
Johnson & Johnson Stock: Is Now the Time to Sell?
October 14, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.